Rapid antigen detection testing in diagnosing group A beta-hemolytic streptococcal pharyngitis

Current clinical practice often relies on throat cultures for diagnosing group A beta-hemolytic streptococci (GABHS) infections. While throat cultures are considered the gold standard, they require time and laboratory resources. Prior research has shown that rapid antigen detection tests (RADTs) may offer faster results but with variable accuracy. However, the extent to which RADTs can replace traditional methods remains uncertain. This gap motivated a closer examination of RADT performance in real-world settings. No prior work had resolved whether RADTs could reliably detect GABHS in a single test. Existing studies have reported conflicting results regarding RADT sensitivity and specificity. These discrepancies highlight the need for more robust validation in clinical populations. This study aimed to clarify the accuracy of RADTs in diagnosing GABHS pharyngitis.

The study aimed to evaluate the diagnostic accuracy of rapid antigen detection tests (RADTs) for group A beta-hemolytic streptococci (GABHS) compared to throat cultures. Researchers focused on determining sensitivity, specificity, and predictive values in two separate patient groups. The first group included 182 patients with acute pharyngitis who underwent both RADT and throat culture. The second group involved 614 patients, with follow-up throat cultures for negative RADT results. The goal was to assess whether RADTs could reliably detect GABHS in a single test. This approach allowed for a direct comparison of diagnostic methods in clinical settings. The study also aimed to address discrepancies in prior findings about RADT accuracy. By analyzing both test types, the researchers sought to clarify RADT performance in real-world use. This information could support or challenge current treatment protocols based on RADT results.

The study used two separate cohorts to compare rapid antigen detection tests (RADTs) with throat cultures. In the first group, 182 patients with acute pharyngitis underwent both RADT and throat culture. In the second group, 614 patients received RADT screening, with throat cultures performed on those who tested negative. All patients with positive RADT results received antibiotic treatment. Researchers calculated diagnostic metrics including sensitivity, specificity, and predictive values. Statistical analysis focused on comparing RADT and throat culture outcomes. The study design allowed for validation of RADT accuracy in a clinical setting. No additional interventions or follow-up beyond throat cultures were used. This approach ensured a direct comparison of diagnostic methods.

The first cohort of 182 patients showed a 12% prevalence of GABHS. RADT sensitivity was 95.45%, and specificity was 96.25%. Positive predictive value reached 77.78%, while negative predictive value was 99.35%. In the second group of 614 patients, four false-negative RADT results were identified, yielding a negative predictive value of 99.18%. Overall, less than 1% of GABHS cases were missed by RADT screening. These results suggest high diagnostic accuracy for RADTs in detecting GABHS. The study found no significant false positives in either cohort. These findings contrast with prior reports of lower RADT accuracy.

The study results suggest that rapid antigen detection tests (RADTs) can detect group A beta-hemolytic streptococci (GABHS) with high accuracy. The authors reported that less than 1% of GABHS cases were missed by RADT screening. These findings support the use of RADTs as a single diagnostic test in clinical settings. The authors propose that RADTs may be as reliable as throat cultures for diagnosing GABHS pharyngitis. The high negative predictive value indicates that RADTs can confidently rule out GABHS in most cases. The authors suggest that treatment protocols based on RADT results are valid. These results contradict previous studies that reported lower RADT accuracy. The authors conclude that RADTs can be used confidently in diagnostic workflows.